SEC 13F Intelligence

Managers / Q3 2024 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$236M
Q3 2024
Positions
35
Filings on Record
30
2019–present window
Filed
Nov 6, 2024
original filing

Summary

Sivik Global Healthcare LLC reported $236M in U.S.-listed holdings across 35 positions for Q3 2024.

Its largest position, XBI, represents 12.5% of the portfolio.

Compared with Q2 2024, the fund opened 9 new positions and exited 12.

Portfolio Metrics

Turnover
+29.4%
vs prior filed quarter
Top-10 Concentration
+50.7%
share of reported value
Largest Position
+12.5%
Spdr S P Biotech Etf
New / Exited
9 / 12
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 77.9%ETP: 12.5%ADR: 7.7%Other: 1.9%
  • Common Stock · 77.9% · $184M
  • ETP · 12.5% · $30M
  • ADR · 7.7% · $18M
  • Other · 1.9% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
XBISPDR S&P BIOTECH ETFNEW+300.0K300.0K+$30M$30M
ABTABBOTT LABSNEW+60.0K60.0K+$7M$7M
MDTMEDTRONIC INCNEW+60.0K60.0K+$5M$5M
RVTYREVVITY INCNEW+40.0K40.0K+$5M$5M
ZBHZIMMER BIOMET HOLDINGS INCNEW+40.0K40.0K+$4M$4M
STEVANATO GROUP SPANEW+140.0K140.0K+$3M$3M
ASNDASCENDIS PHA-ADRNEW+10.0K10.0K+$1M$1M
PUT - SPY 100 @ 565 EXP 10/31/2024NEW+1.5K1.5K+$861,000$861,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

33 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH12.55%$30M300.0K
2LLYELI LILLY & COhistory →COM5.44%$13M14.5K
3THCTENET HEALTHCAREhistory →COM NEW4.57%$11M65.0K
4NVONOVO-NORDISK A/Shistory →ADR4.54%$11M90.0K
5UHSUNIV HEALTH SVChistory →CLASS B4.36%$10M45.0K
6MCKMCKESSON CORPhistory →COM4.19%$10M20.0K
7SYKSTRYKER CORPhistory →COM4.13%$10M27.0K
8BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM3.73%$9M105.0K
9ISRGINTUITIVE SURGhistory →COM NEW3.64%$9M17.5K
10DHRDANAHER CORPhistory →COM3.53%$8M30.0K
11HCAHCA HEALTHCARE INChistory →COM3.44%$8M20.0K
12SGRYSURGERY PARTNERS INChistory →COM3.14%$7M230.0K
13ACHCACADIA HEALTHCREhistory →COM3.09%$7M115.0K
14ABTABBOTT LABShistory →COM2.90%$7M60.0K
15AVTRAVANTOR INChistory →COM2.74%$6M250.0K
16BDXBECTON DICKINSON COhistory →COM2.55%$6M25.0K
17BAXBAXTER INTERNATIONAL INC.history →COM2.41%$6M150.0K
18CORCENCORA INChistory →COM2.38%$6M25.0K
19MDTMEDTRONIC INChistory →SHS2.29%$5M60.0K
20RVTYREVVITY INChistory →COM2.16%$5M40.0K
21WSTWEST PHARMACEUTICAL SERVICES INChistory →COM2.16%$5M17.0K
22CAHCARDINAL HEALTHhistory →COM2.11%$5M45.0K
23S24SELECT MEDICAL HOLDINGS CORPhistory →COM2.07%$5M140.0K
24EHCENCOMPASS HEALTH CORPhistory →COM2.05%$5M50.0K
25VRTXVERTEX PHARMACEUTICALS INC.history →COM1.97%$5M10.0K
26SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.85%$4M140.0K
27ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.83%$4M40.0K
28RGENREPLIGEN CORPhistory →COM1.58%$4M25.0K
29MRVIMARAVAI LIFESCIENCES HLDGS-Ahistory →COM CL A1.50%$4M425.0K
30HUMHUMANA INC.history →COM1.34%$3M10.0K
31TEVATEVA PHARM ADRhistory →SPONSORED ADS1.30%$3M170.0K
32STEVANATO GROUP SPACOM1.19%$3M140.0K
33ASNDASCENDIS PHA-ADRSPONSORED ADR0.63%$1M10.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.